BridgeMD
New treatment option for Critical Illness
Official title Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit
ClinicalTrials.gov ID: NCT07369258
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if listening to music can prevent delirium in older adults admitted to the Intensive Care Unit (ICU). The main questions it aims to answer are: Does listening to music increase the number of days participants are alive and free of delirium and coma during a 7-day period?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Age 65 years or older.
- Negative Confusion Assessment Method for the ICU (CAM-ICU) at the time of randomization.
- Expected ICU length of stay of at least 48 hours based on clinical judgement at admission (e.g., need for mechanical ventilation, vasopressors...
You likely can't join if
- Positive CAM-ICU prior to randomization.
- Acute primary Central Nervous System pathology (e.g., ischemic or hemorrhagic stroke, traumatic brain injury, meningoencephalitis, intracranial...
- Severe chronic cognitive impairment or advanced dementia, defined by a known history of severe functional dependence prior to admission (requiring...
- Unresolved auditory or visual impairment.
- Suspected or confirmed intoxication with drugs or alcohol at admission.
- Uncontrolled psychiatric disease (at least one acute episode requiring intervention in the last 6 months).
See the full eligibility criteria
- Age 65 years or older.
- Negative Confusion Assessment Method for the ICU (CAM-ICU) at the time of randomization.
- Expected ICU length of stay of at least 48 hours based on clinical judgement at admission (e.g., need for mechanical ventilation, vasopressors, invasive monitoring).
- Positive CAM-ICU prior to randomization.
- Acute primary Central Nervous System pathology (e.g., ischemic or hemorrhagic stroke, traumatic brain injury, meningoencephalitis, intracranial hypertension) presenting with altered sensorium (Glasgow Coma Scale at...
- Severe chronic cognitive impairment or advanced dementia, defined by a known history of severe functional dependence prior to admission (requiring permanent assistance for basic activities of daily living such as...
- Unresolved auditory or visual impairment.
- Suspected or confirmed intoxication with drugs or alcohol at admission.
- Uncontrolled psychiatric disease (at least one acute episode requiring intervention in the last 6 months).
- Richmond Agitation-Sedation Scale (RASS) score \ +2 at the time of randomization.
- Medical condition precluding the safe use of headphones (e.g., burns, skull fracture, skin lesions).
- Inability to establish effective communication due to a language disorder or unresolved language barrier.
- Inability of the patient or legal representative to provide informed consent.
- Patients with imminent death, end-of-life care, or limitation of therapeutic effort.
The study team makes the final eligibility decision.
Where it's taking place
- Buenos Aires, Buenos Aires F.D., Argentina
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Buenos Aires, Buenos Aires F.D., Argentina. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.